BRG1 (SMARCA4) Status Dictates the Response to EGFR Inhibitors in Wild-Type EGFR Non-Small Cell Lung CancerRebaz Ahmed(University of Oklahoma Health Sciences Center)CancersDecember 24, 202510.3390/cancers18010062Cited by 0SaveCiteExport RISWatch citationsRelated PapersMolecular Targeting of HuR Oncoprotein Suppresses MITF and Induces Apoptosis in Melanoma Cells|Cancers|2021|14